Topic: Biomarkers

Why Precision Oncology Works – Even if Some Reports on Targeted Therapies Say Otherwise

Published by on May 1, 2018 | Share your thoughts

Why You Should Trust Precision Oncology  Precision oncology and, more specifically, targeted therapies have been under attack since their inception. There’ve been numerous studies and reports claiming that targeted therapies have NOT lived up to expectations and are still inferior to standard therapies. However, a more detailed look at these so-called ineffective studies reveals many design flaws in their methodologies. When the data is presented accurately, precision oncology produces significant benefits in both overall survival and reduced side effects for cancer patients. Problem #1: Using Targeted Drugs Without the Required Biomarker One issue with many studies involving targeted therapies is the use of targeted therapies without prior testing to ensure the relevant biomarker is present in that patient’s tumour tissue. While this may seem like...
Read Article